Funder: American Cancer Society
Due Dates: June 1, 2025 (reviewed in July) | December 1, 2025 (reviewed in December) | Rolling submission
Funding Amounts: $75,000 total for a 1-year project; no indirect costs allowed
Summary: Supports commercialization of ongoing cancer research by funding key experiments to validate and de-risk technologies for licensing or start-up formation.
Key Information: Applicants must be independent investigators at eligible US non-profit institutions; project must be commercially driven and not a new research direction.